Antigens, BCMA
Showing 776 - 800 of 882
Tumor Antigens in Pathologically Proven Stage I, II and III
Completed
- Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)
- Data acquisition and analysis
-
Seoul, Korea, Republic of
- +2 more
Apr 18, 2013
Adult Stem Cell Hematopoetic Transplant Trial in Nashville (High-Dose Trivalent Inactivated Influenza Vaccine (HD-TIV), Standard
Completed
- Adult Stem Cell Hematopoetic Transplant
- High-Dose Trivalent Inactivated Influenza Vaccine (HD-TIV)
- Standard Dose Trivalent Inactivated Flu Vaccine
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center, Clinical Trials Information Pro
Feb 4, 2013
HIV Trial in Barcelona, Madrid (MVA-B, Placebo)
Completed
- HIV Infections
- MVA-B
- Placebo
-
Barcelona, Spain
- +1 more
Feb 21, 2013
Malignant Melanoma Trial in Tuebingen (mRNA coding for melanoma associated antigens, GM-CSF)
Completed
- Malignant Melanoma
- mRNA coding for melanoma associated antigens
- GM-CSF
-
Tuebingen, GermanyDepartment of Dermatology, University of Tuebingen
Jan 15, 2013
Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection Trial in Philadelphia (biological,
Completed
- Cervical Cancer
- +2 more
- HspE7
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jan 23, 2013
Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (tyrosinase peptide, MART-1:27-35 peptide vaccine, gp100 antigen)
Completed
- Recurrent Melanoma
- Stage IV Melanoma
- tyrosinase peptide
- +5 more
-
Rochester, MinnesotaMayo Clinic
Jan 24, 2013
Melanoma, Malignant Melanoma, Melanoma, Experimental Trial run by the NCI (biological, drug, radiation)
Completed
- Melanoma
- +3 more
- aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 29, 2013
RHEUMATOID ARTHRITIS Trial in Chicago (Immune ablation and hematopoietic stem cell transplant)
Terminated
- RHEUMATOID ARTHRITIS
- Immune ablation and hematopoietic stem cell transplant
-
Chicago, IllinoisNorthwestern University, Feinberg School of Medicine
Apr 4, 2013
Insulin Resistance, Prediabetes, Aging Trial in Padova (Metformin, )
Completed
- Insulin Resistance
- +3 more
- Metformin
- placebo
-
Padova, ItalyUniversity Hospital Diabetes Outpatient Clinic
Mar 12, 2013
Epithelial Ovarian, Tubal or Peritoneal Cancer Trial in Durham (tumor peptide vaccine)
Completed
- Epithelial Ovarian, Tubal or Peritoneal Cancer
- tumor peptide vaccine
-
Durham, North CarolinaDuke Comprehensive Cancer Center
Nov 15, 2012
Prostate Cancer Trial in New York (vaccine vehicle only, DC/LNCaP)
Completed
- Prostate Cancer
- vaccine vehicle only
- DC/LNCaP
-
New York, New YorkRockefeller University Hospital
Jan 11, 2013
Refractory Myasthenia Gravis Trial in Syracuse, Burlington (Rituximab (Rituxan))
Completed
- Refractory Myasthenia Gravis
- Rituximab (Rituxan)
-
Syracuse, New York
- +1 more
Jan 15, 2013
Breast Tumors Trial in Hamilton (CD34+ derived DCs)
Completed
- Breast Neoplasms
- CD34+ derived DCs
-
Hamilton, Ontario, CanadaHamilton Health Sciences
Oct 31, 2012
RECOMBINANT BOTULINUM VACCINE A/B Trial in Lexington, (rBV A/B)
Completed
- RECOMBINANT BOTULINUM VACCINE A/B
- rBV A/B
-
Lexington,, KentuckyUniversity of Kentucky Medical Center
Aug 22, 2012
Autism Trial in Houston (Gluten and dry milk, Placebo)
Completed
- Autism
- Gluten and dry milk
- Placebo
-
Houston, TexasThe University of Texas Health Science Center At Houston
Jun 19, 2012
Vitamin A Deficiency Trial in Fajara (Vitamin A (retinyl palmitate).)
Unknown status
- Vitamin A Deficiency
- Vitamin A (retinyl palmitate).
-
Fajara, GambiaMedical Research Council, The Gambia Unit
Nov 12, 2012
Malaria Trial in Harrow, Oxford (AdCh63 ME-TRAP, AdCh63 ME-TRAP; MVA ME-TRAP)
Completed
- Malaria
- AdCh63 ME-TRAP
- AdCh63 ME-TRAP; MVA ME-TRAP
-
Harrow, Middlesex, United Kingdom
- +1 more
Aug 21, 2012
Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Stuart, Las Vegas (MKC1106-MT)
Terminated
- Stage III Melanoma
- Stage IV Melanoma
- MKC1106-MT
-
Los Angeles, California
- +3 more
May 10, 2012
Influenza Trial in Hungary (Vaccination with FAB-6011, Vaccination with FluvalAB)
Completed
- Influenza
- Vaccination with FAB-6011
- Vaccination with FluvalAB
-
Biatorbágy, Pest, Hungary
- +6 more
May 18, 2012
Identifying Saliva Markers in Inflammatory Bowel Disease
Unknown status
- Inflammatory Bowel Diseases
- Salivary samples
-
Jerusalem, IsraelHadassah Medical Organization
Sep 6, 2012
Hepatocellular Carcinoma, Hepatitis C Virus Chronic Infection Trial in Córdoba, Madrid, Pamplona (CP 675,206)
Completed
- Hepatocellular Carcinoma
- Hepatitis C Virus Chronic Infection
- CP 675,206
-
Córdoba, Spain
- +2 more
Jun 7, 2012
Melanoma Trial run by the NCI (Glycoprotein 100 (GP100): 209-217 (210M), Interleukin-2 (IL-2), Montanide ISA 51)
Completed
- Melanoma
- Glycoprotein 100 (GP100): 209-217 (210M)
- +5 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Oct 17, 2012
Pertussis, Diphtheria, Poliomyelitis Trial in Seoul (DTaP-IPV combined vaccine, DTaP vaccine)
Completed
- Pertussis
- +3 more
- DTaP-IPV combined vaccine
- DTaP vaccine
-
Seoul, Korea, Republic of(unnamed)
Apr 13, 2012
Vaccines, Anaemia and Nutritional Status of Children of Northern
Completed
- Schistosomiasis
- +4 more
-
Saint-Louis, SL, SenegalBiomedical Research Center EPLS
Mar 13, 2012
Diphtheria, Tetanus, Pertussis Trial in Korea, Republic of (PENTAXIM™: DTacP IPV//PRP~T combined vaccine, TETRAXIM™: DTacP IPV
Completed
- Diphtheria
- +4 more
- PENTAXIM™: DTacP IPV//PRP~T combined vaccine
- TETRAXIM™: DTacP IPV combined vaccine and ActHIB™: PRP tetanus conjugate vaccine
-
Daejeon, Korea, Republic of
- +13 more
Apr 13, 2012